Back to Search
COREY CUTLER, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1699736686IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
158280(MA)
Education
OTHER
Class of 1996
Research & Publications (20)
Novel drugs for the prevention and treatment of acute GVHD.
PMID 18691107·Curr Pharm Des·2008
6-review
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
PMID 18776081·Blood·2008
8-other
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.
PMID 17138818·Blood·2007
3-trial
Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
PMID 15983555·Biol Blood Marrow Transplant·2005
4-observational
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
PMID 15846292·Biol Blood Marrow Transplant·2005
4-observational
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
PMID 15111932·Biol Blood Marrow Transplant·2004
3-trial
Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation.
PMID 15273708·Bone Marrow Transplant·2004
6-review
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.
PMID 11504750·J Clin Oncol·2001
1-meta
Peripheral blood stem cells for allogeneic transplantation: a review.
PMID 11239165·Stem Cells·2001
6-review
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.
PMID 15039286·Blood·2004
8-other
Self-care agency and symptom management in patients treated for mood disorder.
PMID 11172236·Arch Psychiatr Nurs·2001
8-other
Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes.
PMID 10938473·Nucl Med Biol·2000
7-preclinical
Medical management update: Non-Hodgkin lymphoma.
PMID 19101479·Oral Surg Oral Med Oral Pathol Oral Radiol Endod·2009
6-review
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
PMID 19159415·Transfusion·2009
3-trial
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
PMID 19344418·Br J Haematol·2009
8-other
HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians.
PMID 19385087·Clin Infect Dis·2009
6-review
Luminescent investigations of terbium(III) biosorption as a surrogate for heavy metals and radionuclides.
PMID 19224339·Mol Cell Biochem·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY STREET/D1B30, DANA-FARBER CANCER INSTITUTE
BOSTON, MA 02115 - Phone
- (617) 632-5946
Quick Facts
- NPI
- 1699736686
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile